Patent holdings for IPC class C07D 281/10

Total number of patents in this class: 151

10-year publication summary

6
2
11
11
17
22
12
10
10
5
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Albireo AB
176
33
Elobix AB
17
15
Glaxosmithkline Intellectual Property (no.2) Limited
308
9
RyCarma Therapeutics, Inc.
26
9
Glaxosmithkline Intellectual Property Development Limited
780
7
Armgo Pharma, Inc.
12
7
Shire Human Genetic Therapies, Inc.
190
7
Assembly Biosciences, Inc.
102
3
HK Inno.n Corporation
122
3
VALO Health, Inc.
193
3
Novartis AG
10251
2
Glaxosmithkline LLC
527
2
Merck Sharp & Dohme Corp.
2183
2
Assia Chemical Industries Ltd.
239
2
Les Laboratoires Servier
498
2
Shanghai Institute of Pharmaceutical Industry
127
2
Shanghai Zhongze Therapeutics, Co. Ltd.
5
2
Hainan Jin Rui Pharmaceutical Co., Ltd.
8
2
F. Hoffmann-La Roche AG
7819
1
Hoffmann-La Roche Inc.
3796
1
Other owners 37